Log In
Print
BCIQ
Print
Print this Print this
 

Secukinumab (AIN457)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionHuman mAb targeting IL-17
Molecular Target Interleukin-17 (IL-17)
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today